The current status of an amebiasis vaccine.
Efficient control of infectious diseases requires the development and application of suitable vaccines. Development of vaccines against amebiasis is still in its infancy. However, in recent years progress has been made in the identification of possible vaccine candidates, the route of application and the understanding of the immune response that is required for protection against amebiasis.
Lotter
Hannelore
H
Department of Molecular Parasitology, Bernhard Nocht Institute for Tropical Medicine, Hamburg, Germany.
Tannich
Egbert
E
D000284:Administration, Oral; D003546:Cysteine Endopeptidases / Q000276:immunology; D004749:Entamoebiasis / Q000276:immunology / Q000517:prevention & control*; D006028:Glycosphingolipids / Q000276:immunology; D006801:Humans; D037102:Lectins / Q000276:immunology; D008565:Membrane Proteins / Q000276:immunology; D010544:Peroxidases / Q000276:immunology; D054464:Peroxiredoxins; D015800:Protozoan Proteins / Q000276:immunology; D016052:Protozoan Vaccines / Q000008:administration & dosage
D006028:Glycosphingolipids; D037102:Lectins; D008565:Membrane Proteins; D015800:Protozoan Proteins; D016052:Protozoan Vaccines; C008290:lipophosphonoglycan; C073020:serine-rich protein, Entamoeba histolytica; D010544:Peroxidases; D054464:Peroxiredoxins; D003546:Cysteine Endopeptidases